Since a schizophrenia drug, the first in decades with an innovative mechanism of action, gained US regulatory approval in September, some researchers have proclaimed a new era for psychiatric ...

Summary. Iloperidone is an atypical antipsychotic that recently received marketing approval from the Food and Drug Administration for the acute treatment of schizophrenia. Iloperidone is a pure ...

Antipsychotics commonly used in the treatment of schizophrenia target dopamine receptors ... Researchers have developed a new drug, dubbed LY2140023, which is converted to a selective agonist ...

has approved Cobenfy (xanomeline/trospium chloride), a new medication offering a novel approach to treating schizophrenia, ...

Schizophrenia is a serious mental illness that requires treatment with medication to lessen symptoms. But even if your symptoms go away, you'll need to stay on treatment to avoid a relapse.

Nov 5 (Reuters) - Intra-Cellular Therapies (ITCI.O), opens new tab said on Tuesday its drug to prevent relapses in schizophrenia patients met the main goal of a late-stage trial. Schizophrenia ...